FAKTOR-OPTIONSSCHEIN - MERCK & CO. | Real-time Bid/Ask 11:46:59 2024-06-26 EDT | ||
| 6.1 EUR / 6.11 EUR | -0.08% |
|
| Current month | -27.35% | ||
| 1 month | -15.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 6.02 | -1.47% |
| 24-06-25 | 6.11 | +1.33% |
| 24-06-24 | 6.03 | -10.80% |
| 24-06-21 | 6.76 | -1.60% |
| 24-06-20 | 6.87 | -7.29% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 11:35 am
More quotesStatic data
| Product type | Productos Exóticos |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MG1371 |
| ISIN | DE000MG13713 |
| Date issued | 2024-03-26 |
| Strike | 159.5 $ |
| Maturity | Unlimited |
| Parity | 4.09 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.3 € |
|---|---|
| Lowest since issue | 5.97 € |
| Spread | 0.01 € |
| Spread % | 0.16% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9
USD
Average target price
142.7
USD
Spread / Average Target
+7.34%
- Stock Market
- Certificates
- Certificat
